NCSM · As filed with the SEC
NCS Multistage Holdings cash flow statement, by fiscal year
The statement as NCS Multistage Holdings presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Statements of Cash Flows · USD thousands
| USD thousands | FY2025 Year ended Dec 31, 2025 | FY2024 Year ended Dec 31, 2024 | FY2023 Year ended Dec 31, 2023 | FY2022 Year ended Dec 31, 2022 | FY2021 Year ended Dec 31, 2021 | FY2020 Year ended Dec 31, 2020 | FY2019 Year ended Dec 31, 2019 | FY2018 Year ended Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities | ||||||||
| Net income | 26,037 | 8,138 | (3,111) | (952) | (3,779) | (39,106) | (22,818) | (185,231) |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 5,885 | 5,316 | 4,616 | 4,319 | 4,501 | 5,891 | 10,436 | 17,837 |
| Impairments | — | — | — | — | — | 50,194,000 | 7,919,000 | 227,543,000 |
| Amortization of deferred loan cost | 215 | 208 | 204 | 231 | 281 | 296 | 312 | 334 |
| Write-off of deferred loan costs | — | — | — | 196,000 | — | 606,000 | — | — |
| Gain on patent infringement settlement | — | — | — | — | — | (25,678,000) | — | — |
| Share-based compensation | 6,205 | 5,213 | 5,365 | 6,039 | 6,621 | 8,482 | 12,542 | 10,930 |
| Provision for inventory obsolescence | 857 | 1,136 | 1,235 | 2,542 | 1,754 | 1,820 | 895 | 1,673 |
| Deferred income tax benefit | (10,965) | (380) | 152 | 266 | 96 | (3,202) | 9,000 | (28,840) |
| Gain on sale of property and equipment | (496) | (506) | 258 | (361) | (378) | (592) | (312) | 74 |
| Provision for doubtful accounts | — | — | — | (61,000) | (129,000) | 750,000 | 3,500,000 | 304,000 |
| Net proceeds from patent infringement settlement | — | — | — | — | — | 21,370,000 | — | — |
| Payment of contingent consideration | — | — | — | — | — | — | (3,042,000) | — |
| Change in fair value of contingent consideration | 156 | — | — | — | — | — | 37 | (2,872) |
| (Recovery of) provision for credit losses | (28) | 41 | 162 | — | — | — | — | — |
| Proceeds from note receivable | — | — | 546,000 | 590,000 | 281,000 | 302,000 | — | — |
| Net foreign currency unrealized (gain) loss | (1,693) | 2,365 | — | — | — | — | — | — |
| Proceeds from note receivable | 0 | 61 | — | — | — | — | — | — |
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable—trade | — | — | 4,541,000 | (4,860,000) | (2,558,000) | 19,250,000 | 4,735,000 | (4,213,000) |
| Accounts receivable—trade | (5,499) | (9,154) | — | — | — | — | — | — |
| Inventories, net | 2,209 | (2,806) | (5,758) | (7,678) | (939) | 3,241 | (7,639) | (2,949) |
| Prepaid expenses and other assets | 3,987 | (1,087) | 2,563 | 1,347 | (437) | (3,022) | 488 | (624) |
| Accounts payable—trade | 427 | 2,706 | (2,583) | 1,224 | 2,843 | (3,170) | 2,580 | 219 |
| Accrued expenses | 719 | 4,841 | (649) | (1,777) | 3,000 | (105) | (681) | (2,430) |
| Other liabilities | (5,975) | (3,401) | (2,558) | (2,852) | (3,247) | 534 | (1,606) | (620) |
| Income taxes receivable/payable | 134 | 34 | (209) | 364 | 3,673 | (2,744) | 1,603 | (17,109) |
| Net cash provided by operating activities | 22,175 | 12,725 | 4,774 | (1,423) | 11,583 | 35,117 | 17,949 | 14,026 |
| Cash flows from investing activities | ||||||||
| Purchases of property and equipment | (1,201) | (1,309) | (1,882) | (1,035) | (495) | (2,098) | (6,123) | (11,134) |
| Purchase and development of software and technology | — | — | (310,000) | (96,000) | (338,000) | (55,000) | (251,000) | (4,675,000) |
| Purchase and development of software and technology | (106) | (70) | — | — | — | — | — | — |
| Proceeds from sales of property and equipment | 772 | 592 | 509 | 433 | 389 | 1,094 | 1,372 | 399 |
| Acquisition of business, net of cash acquired | (5,758) | — | — | — | — | — | — | — |
| Proceeds from company-owned life insurance policy | 0 | 1,266 | — | — | — | — | — | — |
| Net cash (used in) provided by investing activities | (6,293) | 479 | (1,683) | (698) | (444) | (1,059) | (5,002) | (15,410) |
| Cash flows from financing activities | ||||||||
| Equipment note borrowings | — | — | — | — | — | — | 835,000 | 1,988,000 |
| Payments on finance leases | — | — | (1,598,000) | (1,463,000) | (1,318,000) | (1,513,000) | (5,021,000) | (2,422,000) |
| Promissory note borrowings | — | — | — | — | — | — | — | 5,360,000 |
| Payments on promissory note | — | — | — | — | — | — | — | (8,673,000) |
| Payments on finance leases | (2,222) | (1,952) | — | — | — | — | — | — |
| Line of credit borrowings | 2,338 | 3,062 | 11,702 | 11,780 | 360 | 5,000 | — | — |
| Payments of line of credit borrowings | (2,338) | (3,062) | (11,758) | (11,724) | (360) | (15,000) | (10,000) | — |
| Treasury shares withheld | — | — | (287,000) | (383,000) | (197,000) | (157,000) | (315,000) | (162,000) |
| Treasury shares withheld | (326) | (267) | — | — | — | — | — | — |
| Distribution to non-controlling interest | (2,700) | (2,050) | (500) | — | (2,750) | (17,550) | (6,000) | (2,300) |
| Proceeds from the issuance of ESPP shares | — | — | — | — | — | — | 1,025,000 | — |
| Payment of deferred loan cost related to ABL facility | — | — | — | (952,000) | — | (553,000) | (871,000) | — |
| Proceeds from the exercise of options for common stock, net | — | — | — | — | — | — | — | 1,079,000 |
| Payment of contingent consideration | — | — | — | — | — | — | (6,958,000) | — |
| Payment of deferred loan cost related to ABL Facility | (55) | — | — | — | — | — | — | — |
| Net cash used in financing activities | (5,303) | (4,269) | (2,441) | (2,742) | (4,265) | (29,773) | (27,305) | (5,130) |
| Effect of exchange rate changes on cash and cash equivalents | — | — | — | — | (251,000) | 17,000 | 470,000 | (2,164,000) |
| Net change in cash and cash equivalents | — | — | — | — | — | — | — | (8,678,000) |
| Cash and cash equivalents beginning of period | — | — | — | — | — | — | 25,131,000 | 33,809,000 |
| Cash and cash equivalents end of period | — | — | — | — | — | — | — | 25,131,000 |
| Net change in cash and cash equivalents | 10,845 | 9,160 | 486 | (5,934) | 6,623 | 4,302 | (13,888) | — |
| Cash and cash equivalents beginning of period | — | 16,720,000 | 16,234,000 | 22,168,000 | 15,545,000 | 11,243,000 | 25,131,000 | — |
| Cash and cash equivalents end of period | — | — | 16,720,000 | 16,234,000 | 22,168,000 | 15,545,000 | 11,243,000 | — |
| Cash and cash equivalents beginning of period | 25,880 | 16,720 | — | — | — | — | — | — |
| Cash and cash equivalents end of period | 36,725 | 25,880 | — | — | — | — | — | — |
| Effect of exchange rate changes on cash and cash equivalents | 266 | 225 | (164) | (1,071) | — | — | — | — |
| Supplemental cash flow information | ||||||||
| Cash paid for interest (net of interest received and amounts capitalized) | 75 | 173 | 377 | 557 | 423 | 929 | 1,070 | 1,373 |
| Cash paid for income taxes (net of refunds) | 1,612 | 431 | (144) | (303) | (3,528) | (1,924) | 122 | 22,356 |
| Noncash investing and financing activities | ||||||||
| Assets obtained by entering into finance leases | — | — | — | — | — | — | 1,383,000 | 2,603,000 |
| Changes in accounts payable related to capital expenditures | — | — | — | — | — | — | — | 783,000 |
| Return of vehicles under finance lease | — | — | — | — | (187,000) | (798,000) | — | — |
| Leased assets obtained in exchange for new finance lease liabilities | — | — | — | — | 3,712,000 | 5,305,000 | — | — |
| Leased assets obtained in exchange for new operating lease liabilities | — | — | — | — | 2,000,000 | 2,572,000 | — | — |
| Changes in accounts payable related to capital expenditures | — | — | — | — | 6,000 | (184,000) | (599,000) | — |
| Assets obtained in exchange for new finance lease liabilities | 1,621 | 2,263 | 1,972 | 1,788 | — | — | — | — |
| Assets obtained in exchange for new operating lease liabilities | 405 | 3,056 | 1,780 | 1,450 | — | — | — | — |
| Debt assumed in acquisition of business | 324 | — | — | — | — | — | — | — |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.